Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This is a randomized, double-blind study comparing 0.1% NVC-422, 0.5% NVC-422 and 1.5% NVC-422 topical gel in children with impetigo.
Epistemonikos ID: adf06b492e3176ad0bc6d85aec187631a7d64208
First added on: May 06, 2024